Once-Weekly Exenatide for Type 2 Diabetes

Name: Work Video:
Duration: 3 min 30 s
Description: In January 2012, a formulation of exenatide that requires only a once-weekly injection (Bydureon) was approved by the FDA. In this manufacturer-funded, placebo-controlled study, about 800 patients with type 2 diabetes (mean glycosylated hemoglobin [HbA1c], 8.5%) were randomized to …
Allan S. Brett
{'id': 'https://openalex.org/W2463440353', 'doi': 'https://doi.org/10.1056/jw201202160000002', 'title': 'Once-Weekly Exenatide for Type 2 Diabetes', 'display_name': 'Once-Weekly Exenatide for Type 2 Diabetes', 'publication_year': 2012, 'publication_date': '2012-01-01', 'ids': {'openalex': 'https://openalex.org/W2463440353', 'doi': 'https://doi.org/10.1056/jw201202160000002', 'mag': '2463440353'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://www.jwatch.org/jw201202160000002/2012/02/16/once-weekly-exenatide-type-2-diabetes', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764501393', 'display_name': 'Journal watch', 'issn_l': '0896-7210', 'issn': ['0896-7210'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5112048102', 'display_name': 'Allan S. Brett', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Allan S. Brett', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5112048102'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': '2012', 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10560', 'display_name': 'Diabetes Management and Research', 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10839', 'display_name': 'Pancreatic function and diabetes', 'score': 0.991, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2780533449', 'wikidata': 'https://www.wikidata.org/wiki/Q417762', 'display_name': 'Exenatide', 'level': 4, 'score': 0.97929204}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9044499}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.8235246}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.6472164}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.49457762}, {'id': 'https://openalex.org/C2778917026', 'wikidata': 'https://www.wikidata.org/wiki/Q43041', 'display_name': 'Hemoglobin', 'level': 2, 'score': 0.4812374}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.45507705}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4529024}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34699863}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.183007}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.085974246}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://www.jwatch.org/jw201202160000002/2012/02/16/once-weekly-exenatide-type-2-diabetes', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764501393', 'display_name': 'Journal watch', 'issn_l': '0896-7210', 'issn': ['0896-7210'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310320239', 'host_organization_name': 'Massachusetts Medical Society', 'host_organization_lineage': ['https://openalex.org/P4310320239'], 'host_organization_lineage_names': ['Massachusetts Medical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.59, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 1, 'referenced_works': ['https://openalex.org/W2072691447'], 'related_works': ['https://openalex.org/W3092124082', 'https://openalex.org/W3010590327', 'https://openalex.org/W2972879364', 'https://openalex.org/W2774157762', 'https://openalex.org/W2526090031', 'https://openalex.org/W2519803668', 'https://openalex.org/W2437862739', 'https://openalex.org/W2347119003', 'https://openalex.org/W2324520177', 'https://openalex.org/W2323571108', 'https://openalex.org/W2152984355', 'https://openalex.org/W2141959598', 'https://openalex.org/W2133648480', 'https://openalex.org/W2130684080', 'https://openalex.org/W2099352903', 'https://openalex.org/W2095143826', 'https://openalex.org/W2014374727', 'https://openalex.org/W1989713397', 'https://openalex.org/W1902551657', 'https://openalex.org/W1484868350'], 'abstract_inverted_index': {'In': [0, 19], 'January': [1], '2012,': [2], 'a': [3, 10], 'formulation': [4], 'of': [5], 'exenatide': [6], 'that': [7], 'requires': [8], 'only': [9], 'once-weekly': [11], 'injection': [12], '(Bydureon)': [13], 'was': [14], 'approved': [15], 'by': [16], 'the': [17], 'FDA.': [18], 'this': [20], 'manufacturer-funded,': [21], 'placebo-controlled': [22], 'study,': [23], 'about': [24], '800': [25], 'patients': [26], 'with': [27], 'type': [28], '2': [29], 'diabetes': [30], '(mean': [31], 'glycosylated': [32], 'hemoglobin': [33], '[HbA1c],': [34], '8.5%)': [35], 'were': [36], 'randomized': [37], 'to': [38], '…': [39]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2463440353', 'counts_by_year': [], 'updated_date': '2024-12-08T07:22:37.392066', 'created_date': '2016-07-22'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
